Global Anti-Biofilm Wound Dressing Market: Key Developments
In October 2021, Imbed Biosciences Inc. received US$ 800,000 in a Commercialization Readiness Pilot (CRP) grant from the National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to support late-stage development of the next-generation wound dressing that can kill bacteria hidden inside the biofilms in wounds and accelerate wound healing.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients